{"title":"Phytotherapy for the Treatment of Lower Urinary Tract Symptoms: Current Position and Unmet Needs.","authors":"Juan Justo Quintas, Stavros Gravas","doi":"10.1016/j.euf.2025.04.014","DOIUrl":null,"url":null,"abstract":"<p><p>Phytotherapy is considered an alternative option to medical treatment for lower urinary tract symptoms (LUTS). However, comparisons between different phytotherapeutics and the development of evidence-based recommendations are hampered by highly variable study results and the limited regulatory framework. Currently, hexanic Serenoa repens is the only agent recommended by the European Association of Urology guidelines on male LUTS. This mini review describes the current situation regarding phytotherapy for LUTS management and provides an insight into research needs for plant extracts in this setting. PATIENT SUMMARY: Our mini review discusses current evidence on plant extracts for the treatment of male lower urinary tract symptoms caused by an enlarged prostate. We highlight limitations and problems that need to be overcome to support routine use of plant extract products for these patients.</p>","PeriodicalId":12160,"journal":{"name":"European urology focus","volume":" ","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European urology focus","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.euf.2025.04.014","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Phytotherapy is considered an alternative option to medical treatment for lower urinary tract symptoms (LUTS). However, comparisons between different phytotherapeutics and the development of evidence-based recommendations are hampered by highly variable study results and the limited regulatory framework. Currently, hexanic Serenoa repens is the only agent recommended by the European Association of Urology guidelines on male LUTS. This mini review describes the current situation regarding phytotherapy for LUTS management and provides an insight into research needs for plant extracts in this setting. PATIENT SUMMARY: Our mini review discusses current evidence on plant extracts for the treatment of male lower urinary tract symptoms caused by an enlarged prostate. We highlight limitations and problems that need to be overcome to support routine use of plant extract products for these patients.
植物疗法被认为是治疗下尿路症状（LUTS）的替代选择。然而，不同植物疗法之间的比较和基于证据的建议的发展受到高度可变的研究结果和有限的监管框架的阻碍。目前，hexanic Serenoa repens是欧洲泌尿外科协会（European Association of Urology）男性LUTS指南推荐的唯一药物。这篇小型综述描述了LUTS管理中植物疗法的现状，并提供了在这种情况下植物提取物研究需求的见解。患者总结：我们的小型综述讨论了目前关于植物提取物治疗前列腺肥大引起的男性下尿路症状的证据。我们强调需要克服的限制和问题，以支持这些患者常规使用植物提取物产品。
期刊介绍：
European Urology Focus is a new sister journal to European Urology and an official publication of the European Association of Urology (EAU).
EU Focus will publish original articles, opinion piece editorials and topical reviews on a wide range of urological issues such as oncology, functional urology, reconstructive urology, laparoscopy, robotic surgery, endourology, female urology, andrology, paediatric urology and sexual medicine. The editorial team welcome basic and translational research articles in the field of urological diseases. Authors may be solicited by the Editor directly. All submitted manuscripts will be peer-reviewed by a panel of experts before being considered for publication.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
